Dream International Limited (FRA:DR1)
Germany · Delayed Price · Currency is EUR 1.600
+0.030 (1.91%)
Last updated: Jul 30, 2025
Blueprint Medicines Income Statement
Financials in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| 5,450 | 5,352 | 6,253 | 4,800 | 3,780 | Upgrade | |
Revenue Growth (YoY) | 1.82% | -14.40% | 30.27% | 26.99% | -4.88% | Upgrade |
Cost of Revenue | 4,196 | 4,008 | 5,024 | 4,185 | 3,119 | Upgrade |
Gross Profit | 1,254 | 1,345 | 1,229 | 614.72 | 660.61 | Upgrade |
Selling, General & Admin | 447.41 | 403.44 | 424.13 | 385.08 | 366.81 | Upgrade |
Other Operating Expenses | -77.68 | -50.23 | -35.95 | -19.94 | -10.02 | Upgrade |
Operating Expenses | 369.73 | 353.21 | 388.19 | 365.14 | 356.79 | Upgrade |
Operating Income | 884.14 | 991.53 | 840.69 | 249.57 | 303.82 | Upgrade |
Interest Expense | -6.56 | -10.28 | -9.13 | -10.46 | -8.01 | Upgrade |
Interest & Investment Income | 47.99 | 38.74 | 19.51 | 20.46 | 15.28 | Upgrade |
Earnings From Equity Investments | 1.23 | 3.96 | 1.74 | 0.9 | -1.02 | Upgrade |
Currency Exchange Gain (Loss) | -1.21 | 2.69 | 23.53 | 5.25 | -0.44 | Upgrade |
EBT Excluding Unusual Items | 925.58 | 1,027 | 876.35 | 265.73 | 309.63 | Upgrade |
Merger & Restructuring Charges | - | - | - | - | -0.82 | Upgrade |
Gain (Loss) on Sale of Assets | 1.36 | 0.88 | 0.11 | -2.08 | 1.03 | Upgrade |
Asset Writedown | -0 | -0.07 | 0.03 | -0.01 | 0.51 | Upgrade |
Other Unusual Items | - | 5.78 | -41.42 | 0.6 | 20.36 | Upgrade |
Pretax Income | 926.94 | 1,033 | 835.06 | 264.23 | 330.7 | Upgrade |
Income Tax Expense | 188.44 | 203.38 | 147.97 | 70.66 | 57.93 | Upgrade |
Earnings From Continuing Operations | 738.5 | 829.85 | 687.1 | 193.56 | 272.78 | Upgrade |
Net Income to Company | 738.5 | 829.85 | 687.1 | 193.56 | 272.78 | Upgrade |
Net Income | 738.5 | 829.85 | 687.1 | 193.56 | 272.78 | Upgrade |
Net Income to Common | 738.5 | 829.85 | 687.1 | 193.56 | 272.78 | Upgrade |
Net Income Growth | -11.01% | 20.78% | 254.97% | -29.04% | -42.87% | Upgrade |
Shares Outstanding (Basic) | 677 | 677 | 677 | 677 | 677 | Upgrade |
Shares Outstanding (Diluted) | 677 | 677 | 677 | 677 | 677 | Upgrade |
EPS (Basic) | 1.09 | 1.23 | 1.02 | 0.29 | 0.40 | Upgrade |
EPS (Diluted) | 1.09 | 1.23 | 1.02 | 0.29 | 0.40 | Upgrade |
EPS Growth | -11.01% | 20.78% | 254.97% | -29.04% | -42.87% | Upgrade |
Free Cash Flow | 541.14 | 1,078 | 407.79 | 10.31 | 112.13 | Upgrade |
Free Cash Flow Per Share | 0.80 | 1.59 | 0.60 | 0.01 | 0.17 | Upgrade |
Dividend Per Share | 0.600 | 0.550 | 0.400 | 0.120 | 0.120 | Upgrade |
Dividend Growth | 9.09% | 37.50% | 233.33% | - | -7.69% | Upgrade |
Gross Margin | 23.01% | 25.12% | 19.65% | 12.81% | 17.48% | Upgrade |
Operating Margin | 16.22% | 18.52% | 13.44% | 5.20% | 8.04% | Upgrade |
Profit Margin | 13.55% | 15.50% | 10.99% | 4.03% | 7.22% | Upgrade |
Free Cash Flow Margin | 9.93% | 20.15% | 6.52% | 0.21% | 2.97% | Upgrade |
EBITDA | 1,033 | 1,133 | 992.44 | 395.83 | 440.8 | Upgrade |
EBITDA Margin | 18.95% | 21.16% | 15.87% | 8.25% | 11.66% | Upgrade |
D&A For EBITDA | 148.43 | 141.07 | 151.75 | 146.26 | 136.98 | Upgrade |
EBIT | 884.14 | 991.53 | 840.69 | 249.57 | 303.82 | Upgrade |
EBIT Margin | 16.22% | 18.52% | 13.44% | 5.20% | 8.04% | Upgrade |
Effective Tax Rate | 20.33% | 19.68% | 17.72% | 26.74% | 17.52% | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.